Analyst Ratings for Cytori Therapeutics, Inc. (CYTX)
CYTX Rating Summary
CYTX Price Target Summary
- Highest: $10.00 (Maxim Group)
- Lowest: $3.25 (Ascendiant Capital)
- Average: $7.08
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.08 (+175.6%)
Avg. $ Target:
$7.08 (+175.6%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/6/2013 | Roth Capital | New Coverage | Buy (N/A) |
8.00 (N/A) |
2.69 | 2.57 | -4.46% | Details |
| 2/20/2013 | Ascendiant Capital | New Coverage | Buy (N/A) |
3.25 (N/A) |
2.65 | 2.57 | -3.02% | Details |
| 9/7/2012 | Maxim Group | New Coverage | Buy (N/A) |
10.00 (N/A) |
3.31 | 2.57 | -22.36% | Details |
| 4/12/2011 | Capstone Investments | New Coverage | Buy (N/A) |
N/A (N/A) |
7.64 | 2.57 | -66.36% | Details |
